Table 2 Clinical characteristics, outcomes, and secondary prevention at discharge
From: Stroke in a resource-constrained hospital in Madagascar
Entire cohort | n = 30 |
|---|---|
Mobilization out of bed | |
Yes | 15 (50%) |
No | 15 (50%) |
Complications | |
Stroke progression | 11 (37%) |
Chest infection | 5 (17%) |
Bedsores | 2 (7%) |
Seizures | 1 (3%) |
Urinary tract infection | 0 |
No | 14 (47%) |
In-hospital stroke mortality | 9 (30%) |
Disability (mRS score) | |
Mild (mRS 0–2) | 1 (3%) |
Moderate (mRS 3) | 3 (10%) |
Severe (mRS 4–5) | 17 (57%) |
Dead (mRS 6) | 9 (30%) |
Survivors | n = 21 |
|---|---|
Swallowing function | |
Normal | 13 (62%) |
Impaired | 0 |
Not testable | 8 (38%) |
Blood pressure (mmHg) | |
Low (<100/60) | 1 (5%) |
Normal (100/60–140/90) | 14 (67%) |
High (>140/90) | 6 (29%) |
Functional status (BI) | |
Independency/slightly dependency (BI 95–100) | 2 (10%) |
Moderate dependency (BI 65–90) | 3 (14%) |
Severe dependency (BI 25–60) | 7 (33%) |
Total dependency (BI 0–20) | 9 (43%) |
Secondary prevention | |
Acetylsalicylic acid | 11 (52%) |
Antihypertensive drug | 9 (43%) |
Warfarin | 0 |
Non-vitamin K dependent oral anticoagulant drug | 0 |
No | 9 (43%) |